Spectra Pharmaceutical Services Inc current clinical study propose dry eye drug Tretinoin produce encourage result base preliminary indications. The compnay test conduct submission Food Drug Administration drug trade name Lacramore. Spectra earlier study show dramatic improvement isolated case occurred. However overall evaluation patient dry eye syndrome demonstrate consistantly beneficial result added. Spectra continue current study undertaking review feasability propose product Spectra development stage company introduce proprietary product hyo-allergenic noniirritating cleanser cleaning eyelid eyelashes. The company begin marketing line ophthalmic drugs. Reuter 